{"schema_version":"secwatch.filing_event.v1","accession":"0001425450-25-000111","form_type":"8-K","ticker":"KIDS","cik":"0001425450","company_name":"ORTHOPEDIATRICS CORP","filed_at":"2025-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.383909+00:00","generated_at":"2026-05-17T01:54:47.593141+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"OrthoPediatrics Q3 revenue $61.2M (+12% YoY); adjusted EBITDA up 56% to $6.2M; raises FY2025 revenue guidance","bullets":["Revenue $61.2M, +12% YoY (17% ex-7D capital); Trauma & Deformity +17%, Scoliosis +4%.","GAAP EPS -$0.50 vs -$0.34; non-GAAP EPS -$0.24 vs -$0.18; net loss $11.8M vs $7.9M.","Adjusted EBITDA $6.2M (+56% YoY); free cash flow usage improved to $3.4M from $11.6M.","FY2025 revenue guidance raised to $233.5-234.5M (+14-15%); adjusted EBITDA guidance reiterated $15-17M.","Recorded $2.3M restructuring charge and $2.3M intangible impairment (ApiFix, Telos, Medtech)."],"urls":{"canonical":"https://secwatch.observer/filing/0001425450-25-000111","json":"https://secwatch.observer/filing/0001425450-25-000111.json","markdown":"https://secwatch.observer/filing/0001425450-25-000111.md","text":"https://secwatch.observer/filing/0001425450-25-000111.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1425450/000142545025000111/0001425450-25-000111-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1425450/000142545025000111/kids-20251028.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:54:47.593141+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}